Crypto News

1 week ago

HCW Biologics (HCWB) Stock: Licensing Deal Fuels Q1 Revenue Surge Amid Nasdaq Compliance Battle

Stocks

HCW Biologics (HCWB) stock posts $6.54M Q1 revenue and $3.47M profit from Trimmune deal, but faces Nasdaq delisting hearing over share price compliance.

The post HCW Biologics (HCWB) Stock: Licensing Deal Fuels Q1 Revenue Surge Amid Nasdaq Compliance Battle appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$BHYP$RKC$USOR13F Filing1D Bull Market Support Band1INCH1inch200-Week MA200-day moving average21Shares21Shares HYPE ETF21shares Hyperliquid21shares Hyperliquid ETF26 EMA3-Day Candlestick3iQ50 week MA@CryptoCupra@Sherlockwhales@Whiplash437

Latest News